Publicaciones en las que colabora con José Manuel Cózar Olmo (21)

2024

  1. Multi-omic study to unmask genes involved in prostate cancer development in a multi-case family

    Cancer Communications

2023

  1. Follow-Up Biomarkers in the Evolution of Prostate Cancer, Levels of S100A4 as a Detector in Plasma

    International Journal of Molecular Sciences, Vol. 24, Núm. 1

2022

  1. Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis

    Cancers, Vol. 14, Núm. 10

2020

  1. Liquid biopsy and prostate cancer. Current evidence applied to clinical practice

    Actas Urologicas Espanolas, Vol. 44, Núm. 3, pp. 139-147

2019

  1. GSTM1 gene expression and copy number variation in prostate cancer patients—Effect of chemical exposures and physical activity

    Urologic Oncology: Seminars and Original Investigations, Vol. 37, Núm. 4, pp. 290.e9-290.e15

  2. The role of miRNAs as biomarkers in prostate cancer

    Mutation Research - Reviews in Mutation Research, Vol. 781, pp. 165-174

2018

  1. Genetic markers a landscape in prostate cancer

    Mutation Research - Reviews in Mutation Research, Vol. 775, pp. 1-10

  2. Improving the genetic signature of prostate cancer, the somatic mutations

    Urologic Oncology: Seminars and Original Investigations, Vol. 36, Núm. 6, pp. 312.e17-312.e23

  3. The influence of nutritional factors on prostate cancer incidence and aggressiveness

    Aging Male, Vol. 21, Núm. 1, pp. 31-39

2017

  1. A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: Biological and clinical implications of EGFR, AR and SNPs

    Oncotarget, Vol. 8, Núm. 41, pp. 70472-70482

  2. Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness

    PLoS ONE, Vol. 12, Núm. 10

  3. Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine

    Molecular Diagnosis and Therapy, Vol. 21, Núm. 2, pp. 167-178

2016

  1. Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk

    Urologic Oncology: Seminars and Original Investigations, Vol. 34, Núm. 10, pp. 431.e1-431.e8

  2. Dormant circulating tumor cells in prostate cancer: Therapeutic, clinical and biological implications

    Current Drug Targets, Vol. 17, Núm. 6, pp. 693-701

2015

  1. Lifestyle and dietary factors in relation to prostate cancer risk

    International Journal of Food Sciences and Nutrition, Vol. 66, Núm. 7, pp. 805-810

  2. Prognostic role of genetic biomarkers in clinical progression of prostate cancer

    Experimental and Molecular Medicine, Vol. 47, Núm. 8

2013

  1. Genetic analysis of the principal genes related to prostate cancer: A review

    Urologic Oncology: Seminars and Original Investigations, Vol. 31, Núm. 8, pp. 1419-1429

  2. The potential impact of adding genetic markers to clinical parameters in managing high-risk prostate cancer patients

    SpringerPlus, Vol. 2, Núm. 1, pp. 1-6

2012

  1. Estudio genético de RNASEL en cáncer de próstata y su relación con la estadificación clínica

    Actas Urologicas Espanolas, Vol. 36, Núm. 5, pp. 306-311

  2. Mitochondrial haplogroups and polymorphisms reveal no association with sporadic prostate cancer in a southern European population

    PLoS ONE, Vol. 7, Núm. 7